Although DDT mimics the actions of estrogen by binding to estrogen receptors, and p,p′-DDE has been demonstrated to be antiandrogenic (Kelce et al. 1995), plasma DDT and DDE levels in our study were not associated with prostate cancer. The gene discussed is ESR1; the disease is prostate cancer.